Project Oncology®

191 Épisodes

1. Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization

   Publié: 29/07/2025
2. Analyzing Toxicity Trends Post-CAR T-Cell Therapy: Implications for Patient Monitoring

   Publié: 23/07/2025
3. Sickle Cell Disease Care: Balancing Disease-Modifying and Curative Therapies

   Publié: 22/07/2025
4. Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks

   Publié: 21/07/2025
5. Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access

   Publié: 23/06/2025
6. Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care

   Publié: 10/06/2025
7. Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden

   Publié: 05/06/2025
8. Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery

   Publié: 05/06/2025
9. Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study

   Publié: 03/06/2025
10. Trial in Progress: Phase 3 MoonRISe-3 Study

    Publié: 01/05/2025
11. First Results From Cohort 4 of the SunRISe-1 Trial

    Publié: 01/05/2025
12. HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)

    Publié: 15/04/2025
13. Targeting CD123 in AML: The Latest Therapeutic Advancements

    Publié: 11/04/2025
14. Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

    Publié: 07/04/2025
15. Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data

    Publié: 28/03/2025
16. AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy

    Publié: 14/03/2025
17. Diagnosis and Management of Metastatic PDAC

    Publié: 13/01/2025
18. Chemotherapy Strategies for Metastatic PDAC

    Publié: 13/01/2025
19. Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care

    Publié: 08/01/2025
20. Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management

    Publié: 07/01/2025